Abstract
Objective: The purpose of this study was to prospectively test the null hypothesis that there is no difference in the clinical effectiveness of azithromycin and erythromycin for the treatment of chlamydia cervicitis in pregnancy.
Methods: All antepartum obstetrical patients underwent routine screening for chlamydia cervicitis using a DNA probe assay (Gen-Probe Pace, San Diego, CA). Women who tested positive for chlamydia cervicitis were prospectively randomized to receive either azithromycin 1 g orally at enrollment, or erythromycin 500 mg orally 4 times a day for 7 days. Sexual partners were referred to the county health department for evaluation and treatment. A test of cure was repeated in 2 weeks. Results were analyzed by chi-square analysis and Fisher's exact test when indicated.
Results: One hundred forty women tested positive for chlamydia cervicitis and agreed to randomization. There were 4 (6.2%) treatment failures in the azithromycin group and 18 (27.7%) in the erythromycin group (P = 0.005). Gastrointestinal side effects were reported by 42 (65.5%) of the women taking erythromycin, but only 12 (19.4%) of those taking azithromycin (P < 0.002). Gastrointestinal side effects and resultant noncompliance were significantly related to treatment failure with erythromycin.
Conclusions: The findings of this study support the conclusion that a single dose of azithromycin is a significantly more effective and better tolerated treatment regimen for chlamydia cervicitis in pregnancy than erythromycin which is currently recommended.
Full Text
The Full Text of this article is available as a PDF (403.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alger L. S., Lovchik J. C. Comparative efficacy of clindamycin versus erythromycin in eradication of antenatal Chlamydia trachomatis. Am J Obstet Gynecol. 1991 Aug;165(2):375–381. doi: 10.1016/0002-9378(91)90097-b. [DOI] [PubMed] [Google Scholar]
- Barbacci M. B., Spence M. R., Kappus E. W., Burkman R. C., Rao L., Quinn T. C. Postabortal endometritis and isolation of Chlamydia trachomatis. Obstet Gynecol. 1986 Nov;68(5):686–690. [PubMed] [Google Scholar]
- Bush M. R., Rosa C. Azithromycin and erythromycin in the treatment of cervical chlamydial infection during pregnancy. Obstet Gynecol. 1994 Jul;84(1):61–63. [PubMed] [Google Scholar]
- Crombleholme W. R., Schachter J., Grossman M., Landers D. V., Sweet R. L. Amoxicillin therapy for Chlamydia trachomatis in pregnancy. Obstet Gynecol. 1990 May;75(5):752–756. [PubMed] [Google Scholar]
- Hopkins S. Clinical toleration and safety of azithromycin. Am J Med. 1991 Sep 12;91(3A):40S–45S. doi: 10.1016/0002-9343(91)90401-i. [DOI] [PubMed] [Google Scholar]
- Johannisson G., Löwhagen G. B., Lycke E. Genital Chlamydia trachomatis infection in women. Obstet Gynecol. 1980 Dec;56(6):671–675. [PubMed] [Google Scholar]
- Oriel J. D., Ridgway G. L. Comparison of erythromycin and oxytetracycline in the treatment of cervical infection by Chlamydia trachomatis. J Infect. 1980 Sep;2(3):259–262. doi: 10.1016/s0163-4453(80)90722-7. [DOI] [PubMed] [Google Scholar]
- Stamm W. E. Azithromycin in the treatment of uncomplicated genital chlamydial infections. Am J Med. 1991 Sep 12;91(3A):19S–22S. doi: 10.1016/0002-9343(91)90396-f. [DOI] [PubMed] [Google Scholar]